This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Bob Rhatigan, CEO of Merz Aesthetics, discusses the company’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.
Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I Obagi is a subsidiary of Waldencast plc.
“The approval of JUVÉDERM VOLUMA XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs,” says Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie, in a news release. “This is the first U.S.
Obagi Introduces Two New Elastiderm Products Obagi Medical is launching Elastiderm Lift Up & Sculpt Facial Moisturizer and Elastiderm Advanced Filler Concentrate.
There remains a significant need for new, innovative treatment for vitiligo and other immune-mediated dermatologic conditions, and we look forward to working together with the CMS team to bringing these products to market in China.”
Brett Fair Named National Sales Director at Sun Pharma Brett Fair is now Sun Pharma’s National Sales Director for the medical dermatology sales team. In this role, Mr. Fair is responsible for the promotion of Winlevi and Absorica LD. Before joining Sun Pharma, he served as Vice President of Corporate Development at Novan Therapeutics.
Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Lexi will be a powerful partner in working with our customers globally to fulfill our shared purpose of fueling people’s confidence through medical aesthetics.” Most recently, Ms.
I am confident that by continuing to elevate our wellbeing strategy, we will cultivate innovation, excellence and a lasting impact throughout the wellness space. Jumeirah’s spas all have a Middle Eastern influence which also underpins the signature brand experience across the portfolio.
Wang, MD, MBE, MBA, Medical Research Director at Laser & Skin Surgery Center of New York, and Medical Director at Laser & Skin Surgery Center of Pennsylvania, in a news release. Six-Month Merger Update Cynosure Lutronic has fully unified its teams across North America.
We are confident that these innovative new products, along with our growing brand loyalty to our market-leading neurotoxin and the associated digital infrastructure and distribution platform will drive our topline growth for years to come.” We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.
We are confident that these innovative new products, along with our growing brand loyalty to our market-leading neurotoxin and the associated digital infrastructure and distribution platform will drive our topline growth for years to come.” We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.
Remington Hospitality, established in 1968, is a premier hotel management company renowned for its innovative and owner-centric approach. Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry.
However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.
IBA supports creative, innovative companies from startups to established multinational businesses of all sizes succeed in the rapidly changing, highly competitive global cosmetics and personal care industry. in Regulatory Affairs for Drugs, Biologics & Medical Devices from Northeastern University. She holds a B.S.
This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance beauty, says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content